Saudi Arabia Analgesics Market Size & Outlook, 2022-2030
Related Markets
Saudi Arabia analgesics market highlights
- The Saudi Arabia analgesics market generated a revenue of USD 422.0 million in 2022 and is expected to reach USD 724.3 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 7% from 2023 to 2030.
- In terms of segment, non-opioid was the largest revenue generating drug type in 2022.
- Compound Medication is the most lucrative drug type segment registering the fastest growth during the forecast period.
Analgesics market data book summary
| Market revenue in 2022 | USD 422.0 million |
| Market revenue in 2030 | USD 724.3 million |
| Growth rate | 7% (CAGR from 2022 to 2030) |
| Largest segment | Non-opioid |
| Fastest growing segment | Compound Medication |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Opioid, Non-opioid, Compound Medication |
| Key market players worldwide | Bayer AG, Assertio Holdings Inc, Johnson & Johnson, GSK PLC, AbbVie Inc, Novartis AG ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 1.1% of the global analgesics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia analgesics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 374.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Analgesics Market Scope
Analgesics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Assertio Holdings Inc | View profile | 30 | 100 South Saunders Road, Suite 300, Lake Forest, IL, United States, 60045 | https://www.assertiotx.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Saudi Arabia analgesics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to analgesics market will help companies and investors design strategic landscapes.
Non-opioid was the largest segment with a revenue share of 51.85% in 2022. Horizon Databook has segmented the Saudi Arabia analgesics market based on opioid, non-opioid, compound medication covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Saudi Arabia analgesics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia analgesics market databook
-
Our clientele includes a mix of analgesics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia analgesics market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia analgesics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia analgesics market report size, by drug type, 2018-2030 (US$M)
Saudi Arabia Analgesics Market Share, 2022 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
